Medication
Therapy Management
Beneficiary
Telephone Interview Script
Hello, my name is [NAME] calling from Econometrica, Inc. May I please speak with [BENEFICIARY NAME]?
WHEN RESPONDENT IS ON THE PHONE:
[IF DIFFERENT THAN PERSON WHO ORIGINALLY ANSWERED THE PHONE] Hello, my name is [NAME] calling from Econometrica, Inc.
We recently sent you a letter about a telephone interview that we are conducting on behalf of the Centers for Medicare & Medicaid Services (CMS).
CMS asked us, Econometrica, to gather opinions of Medicare Part D members about some possible changes to the processes of comprehensive medication reviews and/or targeted medication reviews you may have received through the your Part D plan’s Medication Therapy Management program.
The call will take about 20 minutes to complete. This survey has been approved by the Office of Management and Budget under control number 0938-1185.
In order to help us review what we talked about, we would like to record this call. Do we have your permission to record your voice during this interview? [IF “NO,” DO NOT RECORD; CONTINUE WITH INTERVIEW AND WRITE DOWN KEY ANSWERS AND HIGHLIGHTS.]
Your opinion will help make the medication review process better for you and other Medicare drug plan members.
Beneficiary Telephone Interview Script Questions
Orientation to the CMR for beneficiaries
Q1. After talking with the MTM provider (e.g., your pharmacist), do you feel that you understand more about your medications?
Yes
No
Don’t know
Q2. Did this meeting help you: [check all that apply]
Change how you take your medications to get the most benefit from the drugs you take?
Improve your overall health?
Other
Non-structural changes to SF
Q3. [Refer respondent to mock-up SF visual aids. This includes the Medicare & You printout.] Did you know that the Medicare & You handbook has a section that helps explain what these documents are and what to do with them?
Yes
No
Did not know until now
Other (explain)
Q4. [Direct respondent to refer to appropriate spot on the mock-up MAP] Are the instructions that appear under your name on the medication action plan (MAP) easy or difficult to understand?
Very easy
Easy
Neutral
Difficult
Very difficult
Q4.1. For all responses to Q4 that are not “Very easy”, PROBE: What should be in the instructions to make them easier to understand?
Q5. Based on the instructions you see on the completed MAP, do you know which boxes you should fill in?
Yes
No
Not sure
Q6. [Direct respondent to refer to appropriate spot on MAP] For “My follow-up plan” – what would you write in that box? [Open ended]
Q7. [Direct respondent to refer to the mock-up personal medication list (PML) document at this time] Are the instructions that appear under your name on the PML easy or difficult to understand?
Very easy
Easy
Neutral
Difficult
Very difficult
Q7.1 For all responses to Q7 that are not “Very easy” – PROBE: What should be in the instructions to make them easier to understand?
Q8. Based on these instructions, do you know which boxes on the completed PML you have to fill in?
Yes
No
Not sure
Q9. In the PML, for each of your medications there is a box that says “Why I use it.” What information do you want to go in this box? [Open ended].
Q9.1. PROBE: Do you want the official term for your health condition in this box? Would you rather have it in plain words (e.g., hypertension or high blood pressure)?
Q10. Your pharmacist fills in a lot of the MAP and PML for you. Sometimes your pharmacist may include the goals of taking your medications. For example, if you are taking a medication for arthritis, a goal might be to relieve your pain so you can walk up the stairs more easily. These are called ‘goals of therapy’ and at this time pharmacists do not have to include them. Do you feel that pharmacists should include the goals of therapy in the MAP or PML (in addition to everything else they have to write in)?
Yes
No
Don’t know/unsure
Q11. Where should the ‘goals of therapy’ go? In the PML, or the MAP? [Direct respondent to both mock-up documents if needed]
PML
Q11.1. PROBE: Why?
MAP
Q11.2. PROBE: Why?
Both
Don’t know
Q12. In the past, we have heard from other individuals that say they would like it if their pharmacist prints out a smaller list of their medications that can be folded up and put into a wallet or purse for easy carrying. At this time your pharmacist does not have to print these wallet cards. Do you think pharmacists should be encouraged to print these wallet cards along with the other documents after a CMR?
Yes
No
Maybe
Not sure
Post-CMR Delivery of SF
Q13. After you talk with your pharmacist, he or she provides you with information using the forms we just reviewed. How did you receive your forms after talking with your pharmacist (i.e., after the medication review/CMR)?
Given to me in person
Mailed to me
My caretaker received them on my behalf
Other
Q14. On a scale from 1 to 10, how satisfied are you with this method of getting these documents? [Scale]
Q15. Do you feel these documents help you: [check all that apply]
Change your approach to making your medications work better for you?
Improve your overall health?
Achieve your goals of care?
Electronic SF
At this time, the documents that you get from your pharmacist after a CMR are in paper form. Sometimes they are given to you in person or sometimes they are mailed to you. We want to know your thoughts on other ways to deliver these documents to you that do not require paper.
Q16. Would you like to get these documents through your computer by visiting a website (like a Web portal)?
Yes
No
Don’t know
Don’t have a computer / don’t have access to a computer
Q17. Would you like to get these documents through your smart phone – through an application (“app”)?
Yes
No
Don’t know
Don’t use apps
Don’t have a smart phone / don’t have access to smart phone
Q18. What other ways (besides paper) would you prefer to receive these documents? [Open ended]
Q19. Do you think these electronic methods – such as the Web and phone apps - will be safe with your health information?
Yes
No
Don’t know/doesn’t apply
General Closure Question
Q20. Thank you for spending some time with me today. We appreciate hearing what you have to say and have one last question. What would you suggest to make talking with the pharmacist or the papers you receive afterward more valuable to you?
WRAP UP
Thank you for speaking with me today! Your feedback is very valuable.
Again, my name is [NAME] and my email address is [EMAIL ADDRESS] should you have any questions or comments you want to send to me after we end our call.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Michael Kaiser |
File Modified | 0000-00-00 |
File Created | 2021-01-24 |